Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open- label, phase 3 trial - The Lancet
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial - The Lancet Oncology
avastin - Diabetic Retinopathy
U.K. regulator supports off-label use of Avastin for serious eye condition
Novartis' new macular degeneration drug has to compete against colon cancer drug Avastin. Why? < Pharma < 기사본문 - KBR
Avastin now available in UK for ovarian cancer | Pharmafile
Avastin may fight early breast cancers in certain women | CTV News
Roche - Avastin (bevacizumab)
France wants Avastin used in place of Lucentis - PMLiVE
AVASTIN(R) Vials (400 mg)
File:Bevacizumab label 01.jpg - wikidoc
Legal threat to NHS for using cheap drug Avastin | News | The Times
PDF) Off-label use of bevacizumab for wet age-related macular degeneration in Europe
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use – Policy & Medicine
FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer
Immunotherapy Regimen Approved for Hepatocellular Carcinoma - MPR
SecuringIndustry.com - WHO warns of fake cancer drugs in Uganda
Avastin Injections Are Said to Cause Blindness - The New York Times
PDF) Bevacizumab: Off-label use in ophthalmology
MHRA clarifies position on off-label Avastin - PharmaTimes
10. Avastin | FiercePharma
More Medicare Musings: Why Lucentis is Worth the Price Tag - Eyedolatry
Avastin approval for breast cancer pulled | CBC News
Avastin - FDA prescribing information, side effects and uses
Drug giants threaten NHS with legal action over cheaper drug that could save £84m a year | NHS | The Guardian
ABPI chief exec backs Novartis legal challenge to off-label Avastin - PMLiVE
